PP_1170x120_10-25-21

Kaiser Permanente Washington Health Research Institute (KPWHRI)

NIH clincal trial of investigational vaccine for COVID-19 begins

NIH clincal trial of investigational vaccine for COVID-19 begins

SEATTLE — A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) here. The National Institute of Allergy and Infectious Diseases (NIAID) , <https://www.niaid.nih.gov/diseases-conditions/coronaviruses>, part of the National Institutes of Health, is funding the trial. KPWHRI is part